POMGNT1 and glioblastoma: In addition to its important role during mammalian development, POMGNT1 has recently been linked to the progression of glioblastoma, fatal primary brain tumors with survival time of 12–15 months, as well as the resistance of glioblastoma cells to the chemotherapeutic agent temozolomide (16, 17).